Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Nifenalol hydrochloride | 5704-60-9 | 99.9% | 260.72 | C11H17ClN2O3 | 50 MG
SDP

Catalog No. 5000211590
Encompass_Preferred

Nifenalol hydrochloride is the hydrochloride salt of a β-adrenergic receptor antagonist used in cardiovascular and receptor pharmacology research. It is provided as a high-purity solid reagent with supporting analytical documentation for laboratory use.

  • High purity for reliable experimental results.
  • Hydrochloride salt, stable solid form for storage and handling.
  • Suitable for in vitro adrenergic receptor assays and cardiovascular studies.
  • Certificate of analysis and safety data sheet available for quality and safety documentation.
  • Available in small research pack sizes for laboratory workflows.

Catalog No. 50-002-11590 Supplier Medchemexpress LLC Supplier No. HY10095250MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Nifenalol hydrochloride is the hydrochloride salt of a β-adrenergic receptor antagonist used in cardiovascular and receptor pharmacology research. It is provided as a high-purity solid reagent with supporting analytical documentation for laboratory use.

  • High purity for reliable experimental results.
  • Hydrochloride salt, stable solid form for storage and handling.
  • Suitable for in vitro adrenergic receptor assays and cardiovascular studies.
  • Certificate of analysis and safety data sheet available for quality and safety documentation.
  • Available in small research pack sizes for laboratory workflows.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.